Related Experiment Videos
[PDGF system in vascular smooth muscle cell proliferation]
1Department of Medicine, Kobe University School of Medicine.
Abstract:
Distinct genes encode alpha and beta PDGF receptors which differ in their abilities to be triggered by three dimeric forms of the PDGF molecule. Each receptor is able to independently couple with mitogenic signal transduction pathways, and both are capable of inducing a readily detectable chemotactic response. The vascular smooth muscle cells which express both types of PDGF receptor are mitogenic and chemotactic for PDGFs. Moreover, the alpha receptor is the preferred receptor for platelet PDGF AB as well as the PDGF-AA isoform which is ubiquitously produced in many cells forming atherosclerotic plaques including macrophages, endothelial cells and even arterial smooth muscle cells. The availability of specific PDGF isoforms and the relative expression of each receptor gene product appear to be the major determinants of the PDGF response. An understanding of the molecular mechanisms by which the expression of PDGF and their receptors on vascular smooth muscle will give greater insights as to how these gene products are involved in atherosclerosis.
Insights
Platelet-derived growth factor (PDGF) receptors, alpha and beta, have distinct signaling roles. Their interaction with PDGF isoforms influences vascular smooth muscle cell behavior, impacting atherosclerosis development.
Area of Science:
- Molecular biology
- Cell signaling
- Cardiovascular research
Context:
- Platelet-derived growth factor (PDGF) plays a crucial role in cellular processes.
- Vascular smooth muscle cells (VSMCs) are implicated in cardiovascular diseases like atherosclerosis.
- Distinct alpha and beta PDGF receptors mediate cellular responses to PDGF isoforms.
Purpose:
- To elucidate the differential roles of alpha and beta PDGF receptors in mediating VSMC responses.
- To investigate the impact of various PDGF isoforms on receptor activation and downstream signaling.
- To understand the molecular basis of PDGF-mediated VSMC mitogenesis and chemotaxis in the context of atherosclerosis.
Summary:
- Distinct genes encode alpha and beta PDGF receptors, exhibiting differential binding affinities for PDGF isoforms (PDGF-AA, PDGF-AB).
- Both receptors independently activate mitogenic and chemotactic signaling pathways in VSMCs.
- The alpha receptor preferentially binds PDGF-AA and PDGF-AB, which are prevalent in atherosclerotic lesions.
- VSMCs expressing both receptor types are responsive to PDGF, exhibiting mitogenic and chemotactic activities.
- The interplay between specific PDGF isoforms and receptor expression levels dictates cellular responses.
Impact:
- Provides insights into the molecular mechanisms underlying PDGF signaling in VSMCs.
- Highlights the differential roles of PDGF receptor subtypes in atherosclerosis.
- Suggests potential therapeutic targets for managing atherosclerosis by modulating PDGF signaling pathways.